377731-31-2

Upstream product

• 377731-30-1 methyl 3-tert-butyl-5-(hydroxymethyl)benzoate 
• 558-13-4 carbon tetrabromide 

Downstream Products

• 943641-00-7 3-(bromomethyl)-5-tert-butylbenzoic acid 
• 1261638-95-2 C₂₇H₃₁NO₅S 
• 377731-32-3 5-(3-tert-butyl-5-methoxycarbonyl-benzyl)-2,2-dimethyl-5-[3-[(triphenylmethyl)thio]propyl]-[1,3]dioxane-4,6-dione 

Relevant academic research and scientific papers

HETEROARYL DERIVATIVES AS CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cyt

HETEROCYCLIC CYTOKINE INHIBITORS

The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory, anti-pain or anti-cancer agents. There are further provided m

Naaladase inhibitors for treating retinal disorders and glaucoma

The present invention relates to pharmaceutical compositions and methods for treating a retinal disorder or glaucoma using NAALADase inhibitors.

Thiol-based NAALADase inhibitors

This invention relates to new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, effect

Naaladase inhibitors for treating amyotrophic lateral sclerosis

The present invention relates to pharmaceutical compositions and methods for treating amyotrophic lateral sclerosis using NAALADase inhibitors.